Who to Refer: Kidney Stone Patients
Refer patients with kidney stones to urology for stones >10 mm, obstruction with infection (urologic emergency), failed conservative management after 14 days, or when surgical intervention is indicated; refer to endocrinology for hypercalcemia with suspected primary hyperparathyroidism; and refer high-risk recurrent stone formers to nephrology or specialized stone clinics for comprehensive metabolic evaluation.
Immediate Urology Referral (Emergency)
- Obstructing stone with concurrent urinary tract infection – This is a urologic emergency requiring immediate drainage via ureteral stent or nephrostomy tube 1, 2
- Solitary kidney with obstruction – Requires urgent evaluation to prevent irreversible renal function loss 1
- High-grade obstruction with uncontrolled pain despite oral analgesics 2
Routine Urology Referral
Stone size criteria:
- Stones >10 mm – Unlikely to pass spontaneously and require active intervention 2
- Stones 5-10 mm that fail to pass after 14 days of conservative management with medical expulsive therapy 2
- Stones >2 cm in ureter requiring percutaneous antegrade approach 3
Clinical scenarios:
- Persistent symptoms despite appropriate medical management
- Recurrent urinary tract infections associated with stones 3
- Asymptomatic stones demonstrating growth on serial imaging 2
- Failed extracorporeal shock wave lithotripsy (no fragmentation after initial treatment) 3
Endocrinology Referral for Hypercalcemia
Screen for primary hyperparathyroidism (PHPT) when:
- Elevated serum calcium (>10.5 mg/dL) detected 6 months before or after stone diagnosis 4
- Multiple elevated calcium measurements increase suspicion 4
Critical gap in practice: Only 25% of kidney stone patients with hypercalcemia receive appropriate PTH testing, yet 3-5% have treatable PHPT causing recurrent stones 4. Measure serum PTH in all hypercalcemic stone formers – this simple test can identify a curable cause of recurrent nephrolithiasis and prevent future stones through parathyroidectomy 4.
Nephrology or Specialized Stone Clinic Referral
High-risk patients requiring comprehensive metabolic work-up:
- Age criteria: Children and adults ≤25 years, or adults >25 years with suspected inherited/metabolic disorders 1
- Recurrence pattern: ≥2 stone episodes, bilateral disease, or strong family history 1
- Comorbidities: Chronic kidney disease, end-stage kidney disease, or metabolic bone disorder 1
- Stone complications: 25% of patients with complications need interdisciplinary metabolic evaluation 5
Genetic testing indications (coordinate with nephrology/genetics):
- Recurrent stones in young patients
- Bilateral disease
- Strong family history
- Suspected monogenic forms (12-21% of children/young adults, 1-11% of adults) 1
Primary Care Management (No Referral Needed)
Low-risk, first-time stone formers with:
- Stones <5 mm (90% pass spontaneously) 2
- No obstruction or infection
- Controlled pain with NSAIDs
- Normal renal function
- No hypercalcemia
Basic metabolic screening can be performed in primary care:
- Two 24-hour urine collections (random and restricted diet)
- Serum creatinine, uric acid, ionized calcium, electrolytes 1, 6
- Stone analysis when recovered 2
Common Pitfalls to Avoid
Missing the PHPT diagnosis: The magnitude of calcium elevation matters – test PTH for any calcium >10.5 mg/dL, with higher levels and multiple elevated measurements increasing likelihood 4
Delayed referral for infected obstructed stones: This is an emergency, not a routine referral 1, 2
Inadequate follow-up imaging: Stones require imaging within 14 days to monitor position and assess for hydronephrosis during conservative management 2
Undertreating high-risk recurrent formers: Without proper metabolic evaluation and targeted prevention, recurrence risk is 50-80%; with risk-adapted prevention, this drops to 10-15% 5
Assuming all hypercalcemia is vitamin D toxicity: While vitamin D supplementation causes slightly higher hypercalcemia prevalence, it doesn't increase kidney stone risk 7. Always investigate for PHPT in stone formers with hypercalcemia 4